Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
103.3 USD | -2.13% |
|
+2.60% | -15.99% |
07-10 | Jazz Pharmaceuticals plc Promotes Samantha Pearce to Chief Commercial Officer | CI |
07-09 | RBC Trims Price Target on Jazz Pharmaceuticals to $175 From $176, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.99% | 6.52B | |
+63.05% | 856B | |
+38.89% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+13.72% | 244B | |
+5.07% | 234B | |
+16.34% | 226B | |
+14.63% | 177B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- RBC Trims Price Target on Jazz Pharmaceuticals to $175 From $176, Keeps Outperform Rating